Arrecadação de medicamentos como estratégia em educação e saúde

O Projeto de Extensão foi desenvolvido na Farmácia-Escola Prof. Dr. Antônio Alonso Martinez, que faz parte do NAC (Núcleo de Atendimento à Comunidade), pertencente à Faculdade de Ciências Farmacêuticas da UNESP. Desenvolveu-se um Sistema de Gestão Interno para o controle das amostras grátis e medicamentos que são destinados à doação para a população de Araraquara e região. Realizou-se a orientação e conscientização da população sobre o reaproveitamento de medicamentos e amostras grátis que não seriam mais utilizados e que estavam dentro do prazo de validade. A divulgação foi efetuada com folder explicativo que foi distribuído na Farmácia-Escola, em consultórios médicos e nas faculdades da UNESP do Câmpus de Araraquara. Além disso, houve divulgação na Semana de Atenção Farmacêutica Estudantil (SAFE) e no site e jornal da EPTV. O prazo de validade de cada produto foi verificado e a dispensação desses medicamentos foi feita mediante a apresentação de prescrição médica. Além disso, realizou-se a Assistência Farmacêutica ao informar ao paciente os detalhes da posologia e possíveis interações medicamentosas, de modo a esclarecer eventuais dúvidas dos pacientes. Os medicamentos mais doados foram anti-hipertensivos e hormônios, refletindo no maior número de formas farmacêuticas doadas como sendo comprimidos e cápsulas. O objetivo da divulgação foi alcançado com o aumento de doações realizadas nos meses subsequentes ao início da mesma e com o aumento de 61,9 % em relação ao ano de 2012

A indústria farmacêutica no Brasil: um estudo do impacto socioeconômico dos medicamentos genéricos

Recently, some countries outside the Triad (Japan, Europe and the United States) have assumed an important role in the pharmaceutical scenario, as large producers, among them stand out Brazil. In the 90s, there were major institutional transformations and the pharmaceutical industry has undergone a reverse specialization process, because liberalization has discouraged production of pharmaceutical chemicals and dependence of imports increased. The law of generics medicines in 1999 emerged as an attempt to increase the population's access to medicines equivalent to ones with brand, with more affordable prices. As a result of this law there was a strengthening of the national capital and a major attraction for foreign companies to brazilian market. This study aims to assess the development trajectory of the country, showing how path-dependence has culminated in greater empowerment of national pharmaceutical industries after the Generics Law in 1999

Estratégias Produtivas e Tecnológicas das empresas da Indústria Farmacêutica do Brasil e da Índia: um exame a partir de indicadores aplicados aos fluxos de comércio exterior

This work aims to evaluate the different trajectories in terms of production structure, technological capabilities and performance in international trade of pharmaceutical industries in Brazil and India. For this, we build international trade indicators, based on data provided by the COMTRADE, the UN database for trade. Through the indicators, it is observed that the countries have different results in the catch-up process of the pharmaceutical industry. India has built a productive structure strongly based on generic drugs, with which it is able to greatly meet domestic demand and export to many countries worldwide. Brazil remains in a position of dependence of foreign production, with a high level of imports and exports to the region of Latin America

O desenvolvimento da indústria farmacêutica no Brasil e na Índia: um estudo comparativo

The article shows how the development of the pharmaceutical industry in Brazil and India occurred, and why the industry in these two countries, which until the 1970s were much alike, today show significant differences. The historical analysis of the trajectories of the industries in both countries showed that the Indian industry has a higher technological content, due to, among others, the efficiency of public policies implemented since the 1970s, which were aimed at improving not only production, but also the technological development.

Estratégias tecnológicas em transformação: um estudo da indústria farmacêutica brasileira

The aim of this research is to analyze the extension of changes in technological strategies of a group of Brazilian pharmaceutical companies, which we believe were induced by transformations in the institutional environment during the 1990s. Major institutional changes, such as the enacting of laws that recognized drug patents rights and fostered generic drugs market, have strengthened the market insertion and competitive position of these companies, what would enable an increase in research and development efforts in Brazil. In addition to the literature on technology strategy and drug industry, this study was based on interviews with six Brazilian pharmaceutical companies, all of which were ranked among the top national companies in the industry and have been considered in previous studies particularly active in the process of changing technological strategies. This research confirmed a significant intensification of technology efforts carried out by Brazilian drug companies. Nevertheless, the R&D intensity is still far below the global pattern and innovative impacts are slight.

Desenvolvimento de método analítico para estudo de degradação forçada de cefalotina sódica na forma farmacêutica pó liofilizado para solução injetável

Pós-graduação em Ciências Farmacêuticas - FCFAR

Medicalização em um serviço público de Saúde Mental: um estudo sobre a prescrição de psicofármacos

News of the fifth version of Diagnostic and Statistical Manual of Mental Disorders (DSM-5) bringing an enlarged listing of diagnostic possibilities has fomented discussion concerning the tendency, recognizable in contemporary psychiatric practices, of including ordinary suffering of everyday life in psychiatric diagnosis and submit same to psychopharmacological treatment. The present paper brings to this discussion data obtained from field research about the prescription of psychopharmacs in the psychiatric care of a public mental health service. The results reveal that the psychiatry of the service keeps practically all of its users under prescription, and that medical discharge is extremely rare. The paper organizes elements critical to this practice and concludes that due to its inadequacy as to the objectives of promotion of personalized care concerned with autonomy and citizenship, present in the current national guidelines for public policies in mental health.

A prescrição banalizada de psicofármacos na infância

Atualmente, qualquer sinal de mal-estar pode ser diagnosticado como uma patologia cuja terapêutica será a administração de psicofármacos. A prescrição abusiva de psicofármacos não atinge apenas os adultos, mas também o mal-estar das crianças tem encontrado uma resposta pronta naquele saber autoritário que não resiste à compulsão de medicar. Preocupado com esse processo de medicalização, este trabalho apresenta, através de um estudo de caso de uma criança longamente submetida a uma medicação questionável, uma reflexão crítica sobre a condução de terapêuticas que tendem a produzir pacientes medicados em série, sem abordar a constituição subjetiva do sujeito.

A banalização da prescrição de psicofármacos em um ambulatório de saúde mental

The development of modern psychiatric medications coupled with the wide range currently gained by preventive emphasis in mental health changed the practices of psychiatry, which is no longer focused on treating insanity but is also dedicated to treat any psychiatric suffering through the prescription of psychopharmacos. This study discusses the current process in which medication has been generalized, and presents the results of an exploratory study aimed to examine the patients' medical files, the trajectory of users since they enter the service to the prescription of psychiatric medication in the scope of a Mental Health Outpatient Clinic, in a town in the west of the São Paulo state, Brazil. Results revealed that most (65%) users already arrive at the service with previous prescription of psychiatric medications, and nearly all (99%) of them receive prescriptions of psychiatric medication once forwarded to psychiatric consultations.

Análise químico-farmacêutica do ácido fusídico em formulações de creme

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Medicamentos inadequados para idosos na estratégia da saúde da família

The ageing process can change the pharmacodynamics and pharmacokinetics parameters. Therefore, some medications are considered potentially inappropriate (PIM) for the elderly people, since they can increase the likelihood of occurrence of adverse drug events. The objectives are to estimate the frequency of use of PIM in the elderly people, with potentially hazardous drug interactions (PHDI) and to evaluate the impact of pharmaceutical intervention (PI) for the prescription of safer therapeutic alternatives. A cross-sectional study was performed in a Health Family Strategy (region of Araraquara, SP), between January and February/2012. The medical records of patients aged ≥60 years, that use at least one drug, were consulted for identification of PIM, according to the Beers criteria. The MPI identified were classified considering the Anatomical Therapeutic Chemical Classification System (ATC) and the essentiality of the drug (safety, effectiveness, quality and cost parameters) The inclusion criteria were met by 358 elderly, being that 93 of them (26%) had taken at least one PIM. Of the 114 different drugs prescribed for elderly, ten were classified as PIM, of which four of them act on the central nervous system, four on cardiovascular system and two on the digestive tract. Seven MPI are essential medicines, belonging to national list of essential drugs (RENAME-2010). Fourteen drug interactions were identified, of which two are PHDI (fluoxetine/amitriptyline and digoxin/hydrochlorothiazide).After the PI, there was no change in medical prescriptions of patients with PIM use or with DI. Medical prescriptions of elderly attended in the Health Family Strategy show pharmacotherapeutic safety problems, of which may be responsible for health hazardous for this age group. Although the intervention carried out by letter had been ineffective for the adherence of doctors in prescribing safe alternatives, wide dissemination of the lists that contain PIM and PHDI is need, as well as the inclusion of safer equivalents in RENAME, in order to contribute for rational use of drugs.

Resultados da atenção farmacêutica no Brasil: uma revisão

The practice of pharmaceutical care (PC) is recent in Brazil and little is known about its impact on the health system or patients. The aim of this review was thus to identify the clinical, humanistic and economic outcomes achieved by the practice of PC in Brazil. In order to assess those outcomes, data published in studies from 1997 to 2011 were collected from Lilacs and MEDLINE databases, using the technique of content analysis. Original studies on PC that included pharmacotherapeutic follow-up were considered eligible for this descriptive review. A total of 306 articles were identified through the chosen descriptors. Of those, ten studies were eligible for this review and only two did not report significant results. The others reported increased adherence to pharmacotherapy, resolution of pharmacotherapeutic issues and control of clinical parameters of diseases (such as maintenance or reduction of blood pressure, reduction in HIV viral load and increase in lymphocyte count), promoting improvements in the general state of health and behavioral changes. However, economic impact was not assessed in any article analyzed, nor was a direct measurement of life quality performed. Although there are few studies on the outcomes of pharmaceutical care services in Brazil, it is demonstrated in this review that positive results were obtained when the pharmacist acted as a provider of optimized pharmacotherapy. This may be considered a result of the actions that followed the Brazilian Pharmaceutical Care Consensus of 2002, such as the restructuring of the curricular basis of pharmacy courses. From this point on, Brazilian researchers and pharmacists should think of a strategy to expand the offer of pharmaceutical care beyond academia and reach people in general who need this type of health care.

A importância da atenção farmacêutica após a verificação da qualidade microbiológica de medicamentos contendo paracetamol encontrados em algumas residências de Américo Brasiliense - SP

It is known that a high microbial count can compromise the stability of medicines, thus reducing their therapeutic efficacy. This work tried to demonstrate that the microbial contamination can be directly related to the inadequate handling of the medicines stored in homes, making it possible to draw strategies to reduce the possible risks of medical therapy offering correct information and advising. The objective of this work was to evaluate the quality of the medicines containing paracetamol found in the residences of Américo Brasiliense-SP, using the microbial analysis of non-sterile method described in the Brazilian Pharmacopoeia (1988). The medicine samples (30 samples) were obtained directly from the interviewed local residents, who had received new medicine bottles of the same product. An analysis of viable microorganisms (bacteria and fungus) was carried out to identify pathogens found in the collected samples. Although 90% of the analyzed samples have shown some microbial contamination, the results indicated the absence of pathogenic microorganisms, and the total count of viable microorganisms was below the maximum value for non-sterile (104 UFC/g or mL). It was also verified that the local residents stored the medicines in appropriate places, according to the orientations received when they bought the medicines in pharmacies and drugstores, showing the importance of information for the correct use and conservation of pharmaceuticals.

Acesso, segurança e uso de medicamentos por usuários

The present study aims to identify families who have stock and are making use of medications, as well as assess the conditions of storage, security and use of these drugs. The study was conducted in a city of São Paulo, the interviews were conducted in households enrolled in one of ten units of the Estratégia de Saúde da Família (ESF) that the city provides and the sample was defined by means of stratified random sampling (134households, IC 95%). Data collection was conducted through interviews with a semistructured questionnaire during the first half of 2011. We interviewed 118 (88.0%) households, of which 112 (95.0%) had medications that were stored n insecure or inadequate places in 75.4% of households, non-prescription self-medication was a common practice in 46 (47 4%) households, and lack of identification and security of medications stored was observed in 60 (53.6%) households. Most households had stock of medicines, which were done improperly or unsecure, or have specialties with lack of identification and security, which can lead to poisoning or e ineffective therapy. The Pharmaceutical Assistance under SUS lacks social initiatives, with actions directed for medications users, which can be supplied by the presence of the pharmacist in the ESF, essential for the promotion of racional use of medicines, that, through the Pharmaceutical Care, can identify, correct and prevent possible problems related to drugs.

Atenção farmacêutica em idosos com hipertensão participantes da estratégia saúde da família

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)